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Purpose: To compare diffusion-weighted imaging of the breast performed with a conventional readout-segmented 
echo-planar imaging (rs-EPI) sequence to when using a prototype simultaneous multi-slice single-shot EPI (SMS- 
ss-EPI) acquisition. 
Method: From September 2017 to December 2018, 26 women with histologically proven breast cancer were 
scanned with the conventional rs-EPI and the SMS-ss-EPI at 3 T during the same imaging examination. Four 
breast radiologists (4–13 years of experience) independently scored both acquired series of 25 women (one case 
was used for training) for overall image quality (1: extremely poor to 9: excellent) and artifacts (1: very dis-
turbing to 5: not present). All lesions (n = 52; 40 malignant, 12 benign) were also evaluated for visibility (1: not 
visible, 2: visible if location is given, 3: visible). In addition, lesion characteristics were rated, and a BI-RADS 
score was given. Results were analyzed using visual grading characteristics and the resulting area under the 
curve (AUCVGC), weighted kappa, McNemar test, and dependent-samples t-test when appropriate. 
Results: Overall, radiologists significantly preferred the image quality in rs-EPI over that of SMS-ss-EPI (AUCVGC: 
0.698, P = 0.002). Infolding and ghosting, and distortion artifacts were significantly less apparent in the rs-EPI 
(AUCVGC: 0.660, P = 0.022 and AUCVGC: 0.700 P = 0.002, respectively). Lesions were, however, significantly 
better visible on the SMS-ss-EPI images (AUCVGC: 0.427, P = 0.016). Malignant lesions had significantly higher 
visibility with SMS-ss-EPI (P = 0.035). Sensitivity and specificity were comparable between both sequences 
(P = 0.760 and P = 0.549, respectively). 
Conclusions: Despite the perceived lower image quality and the increased presence of artifacts in the SMS-ss-EPI 
sequence, malignant lesions are better visualized using this sequence.   
1. Introduction 
The high sensitivity of dynamic contrast-enhanced breast MRI (DCE- 
MRI) yields many lesions that cannot be unequivocally classified as 
benign on imaging alone, and for which biopsy is required. In recent 
years, studies have shown that the addition of diffusion-weighted im-
aging (DWI) to DCE-MRI improves the classification of breast lesions, 
which leads in turn to a decrease of biopsies of benign lesions, and a 
corresponding increase in the positive predictive value of biopsies [1–3]. 
Consequently, DWI with evaluation of the corresponding apparent 
Abbreviations: ADC, Apparent diffusion coefficient; AUC, Area under the curve; BI-RADS, Breast imaging reporting and data system; DCE, Dynamic contrast- 
enhanced; DWI, Diffusion-weighted imaging; GRAPPA, Generalized autocalibrating partially parallel acquisition; MIP, Maximum-intensity projection; ROC, Receiver 
operating characteristics; ROI, Region of interest; rs-EPI, Readout-segmented echo-planar imaging; ss-EPI, Single-shot echo-planar imaging; SMS, Simultaneous multi- 
slice acquisition; SPAIR, Spectral attenuated inversion recovery; TE, Echo time; TR, Repetition time; TWIST, Time-resolved angiography with interleaved stochastic 
trajectories; VGC, Visual grading characteristics. 
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diffusion coefficient (ADC) is included in most state-of-the-art breast 
MRI protocols, and consensus recommendations for its implementation 
and reporting were recently published by the international European 
society of breast imaging (EUSOBI) DWI working group [4,5]. 
Still, DWI of the breast is also known for the common presence of 
imaging artefacts. In a recent American college of radiology imaging 
network (ACRIN) trial, 23 of 107 patients were excluded from analysis 
because of insufficient image quality [6]. To improve on this, 
readout-segmented echo-planar imaging (rs-EPI) has been proposed as 
an alternative to single-shot EPI (ss-EPI) due to its reduced sensitivity to 
motion and improved image quality [7–10]. Nevertheless, in practice, 
detection of lesions on DWI sequences is often problematic due to a 
relatively low lesion visibility [11]. Particularly small lesions and lesions 
presenting as non-mass enhancement on DCE-MRI are not always clearly 
visible on DWI scans. The rs-EPI sequence is especially problematic in 
this aspect due to its lower signal-to-noise ratio (SNR) compared to that 
obtained with ss-EPI [8]. Furthermore, another disadvantage of rs-EPI is 
the longer acquisition time compared to that of ss-EPI because each 
readout segment in the k-space requires a separate radiofrequency pulse 
and the subsequent time for recovery of the longitudinal magnetization. 
In order to reduce acquisition time and enable higher spatial resolution 
scans within a clinically acceptable timeframe, the simultaneous 
multi-slice (SMS) acquisition technology was developed. This technique 
allows the simultaneous excitation of multiple slices, providing a scan 
acceleration that is approximately proportional to the number of slices 
simultaneously obtained. This can be used to reduce scan time or in-
crease spatial resolution. The technique can be combined with both 
ss-EPI and rs-EPI. 
In this prospective patient study, we compared a prototype SMS-ss- 
EPI breast diffusion sequence at 3 T to our clinical standard rs-EPI 
sequence. The sequences were evaluated in terms of image quality, 
lesion visibility and diagnosis, and description according to the breast 
imaging reporting and data system (BI-RADS) lexicon. 
2. Material and methods 
2.1. Study population 
Female patients with histologically proven breast cancer and a 
clinical indication for breast MRI were asked to participate in this pro-
spective study for which ethics committee approval and written 
informed consent was obtained. Exclusion criteria were age younger 
than 18 years or inability to provide informed consent. For lesion spe-
cific features, we performed a per-lesion analysis. Malignant lesions 
were included only when a histopathological description of that specific 
lesion was available (either from biopsy or from surgical excision). 
Malignant lesions without any pathological evaluation or clinical 
follow-up were excluded. 
Additional benign lesions diagnosed on imaging only (mammog-
raphy, ultrasound, and the full MRI scan) were included. 
2.2. Image acquisition 
All women were scanned in the prone position on a 3 T MAGNETOM 
Skyra MRI system (Siemens Healthcare, Erlangen, Germany), with a 16- 
channel bilateral breast coil (Siemens Healthcare). Women were scan-
ned with the conventional clinically used rs-EPI sequence and the pro-
totype SMS-ss-EPI during the same clinical examination, prior to 
contrast agent administration. The sequence parameters for the rs-EPI 
were those used as standard of care (Table 1). The parameters for 
SMS-ss-EPI were chosen for optimal performance in a clinical setting 
(Table 1). Therefore, compared to the rs-EPI sequence, the scan time was 
reduced, while the spatial resolution was increased. The rest of the DCE- 
MRI acquisition protocol was performed as the standard-of-care, as 
previously described [12]: one pre- and five post-contrast administra-
tion standard T1-weighted Dixon acquisitions, ultrafast T1-weighted 
TWIST acquisitions during the inflow of contrast, and a T2-weighted 
Dixon acquisition. 
2.3. Image analysis 
A reader study was performed to assess several aspects of image 
quality and lesion appearance in both sequences. Prior to the study, the 
ground truth location of the lesions was annotated based on clinical 
information (pathology and radiology reports) and under the supervi-
sion of an experienced radiologist (13 years of experience with MRI). 
The reader study was carried out by four breast radiologists with 4, 6, 
10, and 13 years of experience. For each reader, two reading sessions, 
separated by at least 2 weeks, were performed in order to avoid possible 
bias in the results due to a direct comparison between images of the 
same patient. The two sequences of each patient were alternatively and 
randomly split between the two reading sessions. Both original DWI 
images and maximum-intensity projection (MIP) reconstructions of 
high-b-value DWI images, were used for image interpretation. 
For the assessment of image quality and artifacts, the entire images 
were used. For image quality, a nine-point scale (1: Extremely poor; 3: 
Moderately poor; 5: Average; 7: Moderately good; 9: Excellent) and for 
artifacts a five-point scale (1: Very disturbing; 2: Moderately disturbing; 
3: Mildly disturbing; 4: Not disturbing but present; 5: Not present) were 
used. Each lesion was shown to the readers, who were asked to describe 
it according to the BI-RADS MRI lexicon [13,14]. In addition, a lesion 
visibility score on a three-point scale (1: Not visible; 2: Only visible if 
location is given; 3: Visible) and a BI-RADS score (1–5) was provided for 
each lesion based upon the interpretation of the DWI images alone. 
Evaluation of all examinations was performed on an in-house-developed 
workstation, using a standardized layout. 
One author blinded to histopathological results determined the site 
of ADC measurement using DCE-images for reference. On the ADC map, 
the ADC values were determined by measuring signal intensity over 
manually-defined regions of interest (ROIs) in the lesions. An ROI 
smaller than the actual solid portion of the breast lesion was carefully 
placed in the enhancing (part of the) lesion to avoid the necrotic portion 
[4]. 
2.4. Statistical analysis 
Visual grading characteristics (VGC) analysis was used to determine 
the difference in image quality, lesion visibility and artifacts scores be-
tween the two techniques, using open source software (VGC analyzer, 
version 1.0.2) [15–18]. VGC is a non-parametric, rank-invariant statis-
tical method derived from receiver operating characteristics (ROC) 
Table 1 
DWI sequence parameters.   
rs-EPI SMS-ss-EPI 
TR, ms 5450 4000 
TE, ms 57 70 
Slices 28 42 
Distance factor 20 % 0 % 
Voxel size, mm3 1.2 × 1.2 × 5.0 0.9 × 0.9 × 4.0 
Fat suppression SPAIR SPAIR 
Readout segments 5 – 
Readout partial Fourier acquisition 5/8 – 
Field of view, mm2 340 × 340 340 × 340 
Bandwidth, Hz/Px 829 1644 





GRAPPA acceleration factor 2 2 
Slice acceleration factor – 2 
Acquisition time, min:s 4:23 2:45 
GRAPPA, generalized autocalibrating partially parallel acquisitions; TE, echo 
time; TR, repetition time. 
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analysis. The area under the VGC curve (AUCVGC) measures the sepa-
ration between the two rating distributions, with AUC > 0.5 indicating 
in our case that rs-EPI was preferred over SMS-ss-EPI. 
To assess whether lesion characteristics were comparable for the two 
sequences, we calculated the inter-method agreement using weighted 
kappa statistics. When lesion visibility was classified as ‘not visible’, 
lesions were excluded for assessment of lesion characteristics. In all 
statistical tests the level of agreement was defined as poor for less than 
0.0, slight for 0.0 to 0.2, fair for between 0.2 and 0.4, moderate for 
between 0.4 and 0.6, substantial for between 0.6 and 0.8, and almost 
perfect for above 0.8. 
Sensitivity and specificity of both sequences was calculated using the 
BI-RADS scores. For a clinical diagnostic setting, BI-RADS 3, 4 and 5 
were considered positive, whereas for a screening setting BI-RADS 4 and 
5 were considered positive. Sensitivity and specificity for both scenarios 
are reported, which were calculated using the pooled scores for all 
readers and compared using McNemar tests [19]. 
For each sequence and by lesion type, mean values of ADCs were 
calculated in manually chosen ROIs. The differences were evaluated 
with the independent-samples t-test. Comparison between rs-EPI and 
SMS-ss-EPI regarding ADC was performed using the dependent-samples 
t-test. 
All statistical analyses were performed using SPSS (version 22, IBM, 
Chicago, IL). Results with 2-sided P values of 0.05 or less were consid-
ered statistically significant. 
3. Results 
3.1. Patient and lesion characteristics 
Twenty-six patients were included from September 2017 to 
December 2018. Six lesions were diagnosed as benign based on radio-
logical evaluation only. All other lesions were pathologically evaluated 
or underwent clinical follow-up. Two patients (with three malignant 
lesions in total) received neo-adjuvant treatment with a pathologically 
proven complete response. After visual inspection, one lesion (lesion 
size: 92 mm) was excluded for further analysis due to fat saturation is-
sues in the SMS-ss-EPI sequence. A study flowchart can be found in 
Fig. 1. For a detailed description of the patient characteristics, histo-
pathological diagnosis, and lesion size, see Table 2. 
3.2. Image quality and artifacts 
Three out of four radiologists significantly preferred the image 
quality in rs-EPI over SMS-ss-EPI (Fig. 2). Only the AUCVGC resulting 
from the assessment of reader 4 was found to be non-significantly 
different than 0.5 (P = 0.065). Overall, the AUCVGC was 0.698 (95 % 
CI = 0.583, 0.804, P = 0.002). 
Overall, artifacts that disturbed image interpretation were relatively 
common. Infolding and ghosting artifacts, and distortion artifacts were 
significantly less visible in the rs-EPI with an AUCVGC of 0.660 (95 % 
CI = 0.514, 0.797, P = 0.022) and 0.700 (95 % CI = 0.571, 0.822, 
P = 0.002), respectively (Fig. 3). Table 3 shows the proportion of 
acceptable artifact ratings for rs-EPI and SMS-ss-EPI. Fig. 4 shows an 
example of a typical infolding and ghosting artifact. 
3.3. Lesion appearance 
Overall, lesions were significantly more visible on the SMS-ss-EPI 
images (AUCVGC was 0.427, 95 % CI = 0.358, 0.498, P = 0.016) 
(Fig. 5). Malignant lesions had significantly higher visibility with SMS- 
Fig. 1. Study flow chart.  
Table 2 
Patient and lesion characteristics.   
N (%) 
Mean age in years ± SD [range] 58.6 ± 9.6 [42–74] 
Indication for breast MRI  
Preoperative staging 18 (72) 
Pre-neoadjuvant staging 4 (16) 
Post-neoadjuvant analysis 3 (12) 
Mean lesion size on DCE-MRI in mm ± SD [range] 14.4 ± 9.6 [3–40] 
Malignant 17.1 ± 9.4 [3–40] 
Benign and high-risk lesions 5.8 ± 3.9 [3–15] 
Lesion type  
Malignant 40 (76.9) 
Invasive carcinoma of no special type (NST) 32 (61.5) 
ILC 4 (7.7) 
Mixed carcinoma 2 (3.8) 
DCIS 1 (1.9) 
Micropapilar carcinoma 1 (1.9) 
Benign and high-risk lesions 12 (23.1) 
Fibroadenoma 1 (1.9) 
Lymph node 3 (5.8) 
Lobular carcinoma in situ 1 (1.9) 
Other 7 (13.5)  
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ss-EPI (P = 0.035). Benign and high-risk lesions were not analyzed 
separately with VGC due to the lack of enough data to draw appropriate 
conclusions. 
In Fig. 6, an example is given of a lesion that is visible on SMS-ss-EPI 
and not visible on rs-EPI. Lesions scored as not visible or only visible if 
location is given by the majority of the readers, had a mean size at DCE- 
MRI of 12.6 mm ± SD 9.5 mm and 10.4 mm ± SD 10.1 mm for rs-EPI and 
SMS-ss-EPI, respectively. Lesions that were only visible in the rs-EPI 
sequence and remained occult on the SMS-ss-EPI ranged from 3 mm to 
6 mm. Conversely, lesions that were only visible in the SMS-ss-EPI 
sequence and remained occult on the rs-EPI ranged from 3 mm to 
26 mm. 
In a clinical diagnostic setting, using BI-RADS 3 or higher as the cut- 
off point, sensitivity and specificity based on BI-RADS assessment did 
not differ significantly (P = 0.280 and P = 0.824, respectively), with a 
pooled sensitivity and specificity of 67.5 % and 72.9 % for rs-EPI and 
72.5 % and 68.8 % for SMS-ss-EPI, respectively. 
In a screening setting, using BI-RADS 4 or higher as the cut-off point, 
sensitivity and specificity based on BI-RADS assessment did also not 
differ significantly (P = 0.760 and P = 0.549, respectively), with a 
pooled sensitivity and specificity of 51.2 % and 91.7 % for rs-EPI and 
53.1 % and 85.4 % for SMS-ss-EPI, respectively. 
The inter-method agreement between the two sequences is shown in 
Table 4. Overall lesion shape has a moderate agreement (K = 0.464, 
p < 0.001); however, non-mass lesions had an overall poor agreement. 
3.4. ADC value 
One malignant lesion with DCIS was excluded from ADC value 
measurements, due to the presence of a hematoma caused by a stereo-
tactic biopsy performed several days before the MR scan. The distribu-
tion of ADC values obtained by rs-EPI and SMS-ss-EPI is shown in 
Table 5 and in the boxplot in Fig. 7. Overall, the mean ADC of malignant 
Fig. 2. The VGC curves of the image quality ratings above a certain threshold 
for the rs-EPI against the same proportion for SMS-ss-EPI at various threshold 
settings. The figure shows the separation between rs-EPI and SMS-ss-EPI per 
reader. The AUCVGC of 0.698 (P = 0.002) shows a higher image quality in 
preference of rs-EPI. The grey line is the reference line were both sequences 
show the same preference. 
Fig. 3. The VGC curve of the artifacts ratings above a certain threshold for the 
rs-EPI against the same proportion for SMS-ss-EPI at various threshold settings. 
The AUCVGC of 0.660 (P = 0.022) and 0.700 (P = 0.002) shows fewer artifacts in 
the rs-EPI. The grey line is the reference line were both sequences show the 
same artifact appearance. 
Table 3 
Average number and percentage of mildly, moderately or very disturbing arti-
fact ratings for rs-EPI and SMS-ss-EPI.   
Mildly, moderately or very disturbing artifacts, 
average number [range] (%)a 
rs-EPI SMS-ss-EPI 
Infolding and ghosting artifacts 14.5 [11–23] (58%) 18.5 [15–22] (74%) 
Distortion artifacts 4.5 [0–13] (18%) 10.3 [1–20] (41%) 
aArtifact assessments are cumulative number and percentages of images that 
were scored as not acceptable in terms of categorized artifact data (not present 
or not disturbing but present vs. mildly, moderately, or very disturbing), aver-
aged across all four observers. 
Fig. 4. Example of a typical ghosting (or Nyquist) artifact in SMS-ss-EPI.  
Fig. 5. The VGC curves of the lesion visibility ratings above a certain threshold 
for the rs-EPI against the same proportion for SMS-ss-EPI at various threshold 
settings. The figure shows the separation between rs-EPI and SMS-ss-EPI for all 
lesions and malignant lesions only. The AUCVGC of 0.427 (P = 0.016) shows a 
higher lesion visibility in preference of SMS-ss-EPI. The grey line is the refer-
ence line were both sequences show the same preference. 
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lesions was lower than that of benign and high-risk lesions. However, 
this was only significant in the rs-EPI (P = 0.042). Within all lesions, the 
mean ADC measurements were lower for SMS-ss-EPI. Especially in the 
malignant lesions, there was a significant difference between the two 
sequences (P = 0.013). Average ROI area was well matched between rs- 
EPI and SMS-ss-EPI sequences for benign and high-risk lesions 
(mean ± SD: 13.0 ± 5.1 mm2 and 12.5 ± 5.4 mm2, respectively) and 
malignant lesions (mean ± SD: 18.0 ± 10.3 mm2 and 17.6 ± 10.4 mm2, 
respectively). 
4. Discussion 
Our study indicates that rs-EPI is superior to SMS-ss-EPI in terms of 
image quality and lesion visibility, which is consistent with previously 
published studies [8–10]. Nevertheless, the SMS-ss-EPI results in better 
visibility of lesions, especially in cases of malignant lesions. These 
findings are clinically relevant, because geometric distortion hamper the 
visual interpretation of DWI sequences and should thus be minimized. 
However, while improved general image quality is desirable, it is not 
relevant if it does not result in an improvement in the visualization of 
lesions. 
The cause of the better lesion visibility on the SMS-ss-EPI is not 
entirely clear. Partly this may be due to the higher resolution of the SMS- 
ss-EPI sequence. However, we encountered lesions of up to 26 mm that 
were only visible in this sequence and remained occult on the rs-EPI. 
Consequently, the lower visibility cannot only be explained by spatial 
resolution but it is likely also caused by the inherently lower SNR of the 
rs-EPI sequence. Unfortunately, it is difficult to pinpoint the exact cause 
of the lower visibility of the lesions in the rs-EPI sequence, as several 
settings differed between the two sequences. This might be overcome by 
Fig. 6. MR images of a 67-year-old woman with a 26 mm invasive carcinoma NST in her right breast (see arrow) with an average image quality score of 5.6 and 4.0 
for rs-EPI and SMS-ss-EPI, respectively. The lesion was scored as not visible (n = 3) and only visible if location is given (n = 1) in the rs-EPI sequence, whereas it was 
scored as visible by all readers in the SMS-ss-EPI sequence. Contrast-enhanced T1-weighted MR images (A), diffusion-weighted images (DWI) (B; b = 850 and C; 
b = 800), the corresponding ADC maps (D and E), and maximum intensity projections (MIP) (F and G) for rs-EPI and SMS-ss-EPI, respectively. 
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phantom studies in which it is feasible to adapt one parameter at a time 
to evaluate the effect on image quality, an approach that is simply not 
feasible in patients. However, lesions in such phantoms need to be 
realistic and variable in order to represent the high variability of lesions 
observed in humans. Future clinical studies should focus on the use of 
SMS on both sequences and the interplay among different spatial reso-
lutions, fat saturation, and b-values, to investigate which combination 
gives the best DWI setting in clinical use. Despite the lower visibility of 
the malignant lesions on the rs-DWI sequence, the sensitivity of both 
sequences, using BIRADS 4 or higher as cut-off is similar. In other words, 
most malignant lesions that were visible only at the SMS-ss-DWI 
sequence were scored BI-RADS 3 by the evaluating radiologists, which 
underlines that mainly subtle lesions are missed on the rs-DWI sequence. 
Overall, SMS-ss-EPI obtained lower mean ADC values in comparison 
to rs-EPI. Also, the mean ADC value in malignant lesions was lower in 
comparison to that in benign and high-risk lesions. This is not 
completely attributable to the acquisition parameters and can also not 
be directly attributed to increased image noise, as the SNR is lower in rs- 
EPI. Although there were significant differences in mean ADC values 
between the two sequences and the benign and high-risk, and malignant 
lesions, in practice these differences were small, and the values over-
lapped. Clinically, this may result in the need to adopt different ADC 
thresholds for different sequences [4,20]. 
Comparing the present results with those reported in other studies 
analyzing breast lesion characteristics in DWI images, the present sen-
sitivities of both sequences fall below values reported previously (51.2 % 
and 53.1 % vs. up to 91 % for rs-EPI, SMS-ss-EPI, and sensitivity 
described in literature [11,21], respectively). However, the majority of 
studies are based on mass lesions only, because the diagnostic accuracy 
in non-mass enhanced lesions is limited [22]. This lesion characteristic 
was not considered for patient selection in this study. 
The present specificity of both sequences is comparable with the 
values in literature (91.7 % and 85.4 % vs. up to 87 % for rs-EPI, SMS-ss- 
EPI and specificity described in literature, respectively [11,21,23]). 
Further, our results are in the given range reported in meta-analysis 
[23]. It should be noted that different DWI sequences were pooled in 
the meta-analysis, causing mixing of rs-EPI and ss-EPI data. In this study 
the sensitivity and specificity of both sequences were similar. 
Ohlmeyer et al. and Frost et al. both describe that SMS acquisitions 
do not introduce serious artifacts [24,25]. However, Filli et al. describe 
an increase of shading in the prepectoral region and ghosting [26]. 
Shading was not commonly encountered in our study, but ghosting was 
significantly visible in this study. In fact, one of the most common ar-
tifacts encountered in this study was Nyquist ghosting in the image 
phase-encoding direction (see Fig. 4). This is a well-known and common 
artifact caused by the alternating nature of EPI readout, which leads to 
inconsistencies between k-space lines of opposite polarity [27]. In breast 
imaging, this is exacerbated by unsuccessful or insufficient fat satura-
tion. Like in conventional ss-EPI sequences, these artifacts were more 
commonly found in the SMS-ss-EPI acquisitions than in the rs-EPI ac-
quisitions, which would currently be a major drawback for the use of 
SMS-ss-EPI in practice. However, recent studies proposed alternative 
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ADC values for rs-EPI and SMS-ss-EPI.  
ADC (x10− 3 mm2/sec) rs-EPI SMS-ss-EPI Pb  
(Mean ± SD)  
All lesions 1.06 ± 0.41 0.94 ± 0.41 0.003 
Benign and high-risk 1.33 ± 0.52 1.20 ± 0.60 0.145 
Malignant 0.97 ± 0.33 0.85 ± 0.30 0.013 
Pa 0.042 0.069  
Pa: p-value based on the independent-samples t-test comparing measurements 
between benign and high-risk, and malignant lesions. 
Pb: p-value based on the dependent-samples t-test of paired rs-EPI and SMS-ss- 
EPI measurements within each MRI exam. 
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which might increase the usefulness of the SMS-ss-EPI approach, also 
exploiting the documented higher sensitivity in our study. 
A commonly postulated hypothesis is that DWI may be used as a fully 
non-invasive screening technique for breast cancer. DWI sequences 
represent a fast and non-invasive approach compared to the current 
standard full diagnostic protocol and therefore might play an important 
role in screening and detection of suspicious breast lesions without 
exposing the patient to additional ionizing radiation or intravenous 
contrast agents. With the addition of MIP, a short examination and 
reading time can be obtained. However, it may be clear from our anal-
ysis that neither the SMS-ss-EPI sequence nor the rs-EPI sequence is, 
according to our experience, good enough for unenhanced screening 
purposes yet. These findings are in line with prior research that, 
although obtaining encouraging results, shows a definite inferiority of 
DWI-only approaches compared to contrast-enhanced MRI of the breast 
[11,21]. 
Overall image quality and spatial resolution need to be improved 
substantially in order to make DWI feasible as a standalone screening 
sequence. In recent studies, DWI at much higher spatial resolutions, 
either by image manipulation or acquisition, was evaluated [29–31]. 
However, acquisition times were in the order of 15 min, and therefore 
such an approach is currently not yet clinically feasible. Another 
approach to DWI screening is the use of strong background suppression 
and high b-values, which already have been shown to improve lesion 
visibility [32,33]. Nevertheless, in case the image quality and spatial 
resolution will be improved in the future and the DWI sequence is used 
as a first screening modality, further diagnostic examination can be 
performed in case a suspicious breast lesion is detected by DWI 
screening. 
Our study has some limitations. First, we performed a lesion-based 
analysis, rather than a patient-based analysis. This implies that 
distinct foci from single multifocal lesions were actually regarded as 
separate lesions, whereas in many studies these would be regarded as 
parts of the same tumor and hence would be regarded as positive in a 
sensitivity analysis. However, this finding adds to the statement that 
DWI is currently not very good for the detection of small and non-mass 
lesions. Second, our readers were aware of the fact that all scans con-
tained lesions. By having readers score multiple tumor foci in order to 
also include smaller lesions, and by explicitly asking whether lesions 
were clearly visible, or only visible when indicated, we intended to 
overcome these biases. Third, three patients who received neo-adjuvant 
treatment were included for analysis which may introduce bias. How-
ever the ground truth location of these lesions were annotated based on 
clinical information and visibility on DCE-MRI. Fourth, in this study we 
used the SMS only on the ss-EPI. As stated above in future clinical studies 
it is important to compare the use of SMS on both sequences. 
5. Conclusions 
Our results suggest increased visibility of malignant lesions using the 
SMS-ss-EPI compared to the conventional clinically used rs-EPI. 
Although the overall image quality is much better in rs-EPI, other fac-
tors including patient-related issues and the choice of acquisition pa-
rameters affect the image quality and should be further investigated. 
Still, further development of the SMS-ss-EPI sequence is needed for 
improved image quality, decreased presence of artifacts, and even better 
lesion visibility. 
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